Ask Warren

JIN Yang Pharmaceutical

007370 · KOSDAQ · ₩007370 · 진양제약

₩3,405▼ ₩50 (1.45%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩33B₩32B₩30B₩29B₩30B₩31B₩27B₩32B
Cost of sales₩11B₩11B₩11B₩10B₩11B₩11B₩11B₩11B
Gross profit₩22B₩22B₩20B₩19B₩20B₩20B₩16B₩20B
Operating income₩4.2B₩3.4B−₩2.9B−₩940M₩2.5B₩3.8B₩3.1B₩4.4B
Net income₩2.2B₩2.3B₩19B−₩991M₩1.7B₩2.3B₩2.5B₩22B
Net income to shareholders₩2.2B₩2.3B₩19B−₩991M₩1.7B₩2.3B₩2.5B₩22B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩274B₩271B₩268B₩231B₩229B₩230B₩228B₩228B
Current assets₩48B₩47B₩46B₩46B₩45B₩46B₩43B₩44B
Cash and equivalents₩1.1B₩2.7B₩2.2B₩4.1B₩372M₩3.1B₩1.8B₩3.3B
Total liabilities₩112B₩112B₩108B₩104B₩102B₩107B₩108B₩110B
Current liabilities₩92B₩91B₩88B₩88B₩14B₩18B₩20B₩21B
Borrowings₩378M₩843M₩1.1B₩77B₩77B₩78B₩79B₩83B
Total equity₩162B₩160B₩160B₩128B₩126B₩123B₩120B₩118B
Shareholders' equity₩162B₩160B₩160B₩128B₩126B₩123B₩120B₩118B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩8B₩4.5B−₩3.5B₩1.6B₩660M₩2.6B−₩2.1B₩5.3B
Capital spending₩727M₩78M−₩371M₩1.7B−₩41M₩338M−₩90B₩74B
Free cash flow₩7.3B₩4.5B−₩3.8B−₩74M₩620M₩2.3B−₩92B−₩69B
Dividends paid₩4.2B−₩2.1B₩0₩0₩3.4B−₩1.7B₩0₩0

Consolidated where available. Amounts in won.

Also known as: JIN Yang Pharmaceutical / 진양제약 / 007370 / KRX:007370

Source: KRX statistical information